Role of Dose Intensity in Conservative Treatment ofAnal Canal Carcinoma

Publisher： Karger

E-ISSN： 1423-0232|55|6|525-532

ISSN： 0030-2414

Source： Oncology, Vol.55, Iss.6, 1998-10, pp. : 525-532

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transitional‐Cell Cloacogenic Carcinoma of the Anal Canal: Case Report

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 23, Iss. 10, 1975-10 ,pp. : 477-479

John Wiley & Sons Inc

Access to resources Recommend Favorite

Successful Treatment of Metastatic Anal Canal Adenocarcinoma with mFOLFOX6 + Bevacizumab

By  

Case Reports in Oncology, Vol. 9, Iss. 1, 2016-04 ,pp. : 249-254

Karger

Access to resources Recommend Favorite

Superficial anal canal squamous cell carcinoma diagnosed using narrow‐band imaging and treated by endoscopic submucosal dissection

By  

DIGESTIVE ENDOSCOPY, Vol. 27, Iss. 5, 2015-07 ,pp. : 627-629

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase 1 study of cetuximab in combination with 5‐fluorouracil, cisplatin, and radiotherapy in patients with locally advanced anal canal carcinoma

By  

CANCER, Vol. 119, Iss. 16, 2013-08 ,pp. : 2973-2980

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term results of weekly/daily cisplatin‐based chemoradiation for locally advanced squamous cell carcinoma of the anal canal

By  

CANCER, Vol. 119, Iss. 21, 2013-11 ,pp. : 3769-3775

John Wiley & Sons Inc

Access to resources Recommend Favorite